Category Navigation:

Search Site

Good Manufacturing Practices for Pharmaceuticals, Sixth Edition

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

Good Manufacturing Practices for Pharmaceuticals, Sixth Edition

By Joseph D. Nally, Nallianco LLC, New Vernon, New Jersey, USA

Email to a Friend
$270.00
Add Items to Cart

This publication is available in both printed and electronic format:

    

Book Specifications

  • Available to Purchase
  • Published: December 2006
  • ISBN: 9780849339721
  • eISBN: 9781420020939
  • Sixth Edition
  • 424 pages
  • Format: Hardcover
  • Size: 7" x 10"
  • 19 Black and White Illustrations

Quick Overview

Offering a wide assortment of policy and guidance document references and interpretations, this book is significantly expanded to reflect the increase of information and changing practices in CGMP regulation and pharmaceutical manufacturing and control practices worldwide.
$270.00
Add Items to Cart

Navigation

With global harmonization of regulatory requirements and quality standards and national and global business consolidations ongoing at a fast pace, pharmaceutical manufacturers, suppliers, contractors, and distributors are impacted by continual change. Offering a wide assortment of policy and guidance document references and interpretations, this Sixth Edition is significantly expanded to reflect the increase of information and changing practices in CGMP regulation and pharmaceutical manufacturing and control practices worldwide. An essential companion for every pharmaceutical professional, this guide is updated and expanded by a team of industry experts, each member with extensive experience in industry or academic settings.

  • Building on the solid foundation of the Fifth Edition and previous editions, this Sixth Edition provides readers with fundamental knowledge of CGMP regulations and current industry applications and practices. Each chapter has been updated and this text
  • supplies new and must-have information regardingthe latest FDA guidance documents
  • quality systems approach
  • risk analysis and management
  • quality by design
  • standard operating procedures (SOPs), validation practices, and process analytical technology (PAT) initiativescontracting and outsourcingGMPs for Clinical Trial Materials